Clinical Trial Update: Effects of Melatonin as a Novel Antioxidant and Free Radicals Scavenger in Neonatal Sepsis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating melatonin as an antioxidant and free radical scavenger for neonatal sepsis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Sepsis

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Mohamed Hussein Metwally | Conditions: Neonatal Sepsis | Phase 1, Phase 2 | Status: COMPLETED